ヒトパピローマウイルスの改良型ワクチンおよびその使用方法

Title:

ヒトパピローマウイルスの改良型ワクチンおよびその使用方法

Document Type and Number:

Japanese Patent JP6517779

Kind Code:

B2

Abstract:

Improved anti-HPV immunogens and nucleic acid molecules that encode them are disclosed. Immunogens disclosed include those having consensus HPV6 E6E7, HPV11 E6E7, HPV16 E6E7, HPV18 E6E7, HPV31 E6E7, HPV33 E6E7, HPV39 E6E7, HPV45 E6E7, HPV52 E6E7, and HPV58 E6E7. Pharmaceutical composition, recombinant vaccines comprising DNA plasmid and live attenuated vaccines are disclosed as well methods of inducing an immune response in an individual against HPV are disclosed.

More Like This:

JP2018158954	LACTIC ACID BACTERIA-CONTAINING COMPOSITIONS, ORAL PHARMACEUTICAL COMPOSITIONS FOR TREATING HPV INFECTION AND/OR HPV-ASSOCIATED TUMORS, AND MUCOSAL IMMUNITY-INDUCING AGENTS
WO/2022/212505	OPTIMAL PRODUCTION OF SARS-COV-2 VIRUS-LIKE PARTICLES (VLPS) PRODUCED IN MAMMALIAN CELLS
JP2004501979	Methods and compositions for oral vaccination

Inventors:

David Weiner
Yang Jian

Application Number:

JP2016501747A

Publication Date:

May 22, 2019

Filing Date:

March 12, 2014

Export Citation:

Click for automatic bibliography generation Help

Assignee:

AstraZeneca UK Limited
Inobio Pharmaceuticals, Incorporated

International Classes:

A61K39/12; A61K48/00; A61P31/20; A61P37/04

Domestic Patent References:

JP2006501825A

Foreign References:

US20120053509

Attorney, Agent or Firm:

Atsushi Aoki
Takashi Ishida
Fukumoto product
Tetsuji Koga
Yoichi Watanabe
Ryotaro Takei
Takahide Sasaki

Previous Patent: ワイヤメッシュ加熱セグメントを有する流体ヒータ

Next Patent: 加速劣化試験法に基づいた高分子部品に対する弁の予測